Yingjun Ding - Concepedia

Author

Yingjun Ding

Huazhong University of Science and Technology ORCID

Also Known As

Y. Ding, Y.J. Ding, Yandi Ding, Ying-Jun Ding, Ying-jun Ding, Yingjun Ding

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Huazhong University of Science and Technology Union Hospital University of Oklahoma Health Sciences Center Tongji Hospital Wuhan Union Hospital

About

Yingjun Ding is an author at Huazhong University of Science and Technology specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	607
2	Pharmacology	4	4	127
3	Health Sciences	1	1	12
4	Biochemistry	1	1	12
5	Immunology	1	1	50

Yingjun Ding

Publications

Citations

H-Index

Page 1

	Year	Citations
The Th17/Treg imbalance in patients with acute coronary syndrome Xiang Cheng, Yingjun Ding, Qingqing Fu, Clinical Immunology ThrombosisTh17/treg ImbalanceCardiovascular DiseaseCardiologyMedicine	2008	480
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis Tingting Tang, You Seon Song, Yingjun Ding, Journal of Lipid Research	2011	92
Defective Circulating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>CD127<sup>low</sup> Regulatory T-cells in Patients with Chronic Heart Failure Tingting Tang, Yingjun Ding, Yuhua Liao, Cellular Physiology and Biochemistry	2010	84
Characteristics of Sjogren's syndrome in rheumatoid arthritis Jing He, Yingjun Ding, Min Feng, Lara D. Veeken	2013	75
Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure Xiang Cheng, Yingjun Ding, Chunyan Xia, Journal of Cardiac Failure InflammationThrombosisHeart FailureChronic Heart FailureCardiovascular Disease	2008	54
Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE−/− mice through modulation of Th1/Th2 balance Xiang Cheng, Yong Chen, Jiang-jiao Xie, Journal of Molecular and Cellular Cardiology InflammationVascular DiseaseSuppressive OligodeoxynucleotidesAtherosclerosisApoe−/− Mice	2008	50
Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency Lin Yang, Guanghai Yang, Yingjun Ding, Oncology Reports	2018	45
CD82 Restrains Pathological Angiogenesis by Altering Lipid Raft Clustering and CD44 Trafficking in Endothelial Cells Quan Wei, Feng Zhang, Mekel M. Richardson, Circulation	2014	42
Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency<i> in Vitro</i> Lin Yang, Guanghai Yang, Yingjun Ding, Journal of Cancer	2018	41
Poly (ADP-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in ApoE-/- Mice with Hyperhomocysteinemia Jiang-jiao Xie, Yuhua Liao, Jian Chen, Journal of Atherosclerosis and Thrombosis	2009	23

Page 1